Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 232

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

4-Hydroxy-nonenal—A Bioactive Lipid Peroxidation Product

Open access
Schaur, Rudolf, Siems, Werner, Bresgen, Nikolaus, Eckl, Peter·2015·Biomolecules

Abstract

This review on recent research advances of the lipid peroxidation product 4-hydroxy-nonenal (HNE) has four major topics: I. the formation of HNE in various organs and tissues, II. the diverse biochemical reactions with Michael adduct formation as the most prominent one, III. the endogenous targets of HNE, primarily peptides and proteins (here the mechanisms of covalent adduct formation are described and the (patho-) physiological consequences discussed), and IV. the metabolism of HNE leading to a great number of degradation products, some of which are excreted in urine and may serve as non-invasive biomarkers of oxidative stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom5042247

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 342

  1. Schauenstein, 1963, Ueber die Reaktion von 9,12 Linolsaeureester in Wasser 6. Mitteilung: Chromatographische Untersuchungen ueber die Zusammensetzung des Praeparates LHPO und die Isolierung der einzelnen tumor-wirksamen Hydroperoxid-Komponenten, Chem. Mon., 94, 11, 10.1007/BF00900233 · doi:10.1007/bf00900233
  2. Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
  3. Poli, 2008, 4-Hydroxynonenal: A membrane lipid oxidation product of medicinal interest, Med. Res. Rev., 28, 569, 10.1002/med.20117 · DOI · Paper page
  4. Schaur, 2003, Basic aspects of the biochemical reactivity of 4-hydroxynonenal, Mol. Asp. Med., 24, 149, 10.1016/S0098-2997(03)00009-8 · DOI · Paper page
  5. Dubinina, 2010, Role of 4-hydroxy-trans-2-nonenal in cell functions, Biochem. Moscow, 75, 1069, 10.1134/S0006297910090014 · DOI
  6. Fritz, 2013, An overview of the chemistry and biology of reactive aldehydes, Free Rad. Biol. Med., 59, 85, 10.1016/j.freeradbiomed.2012.06.025 · DOI · Paper page
  7. Zarkovic, 2013, Pathophysiological relevance of aldehydic protein modifications, J. Proteomics, 92, 239, 10.1016/j.jprot.2013.02.004 · DOI
  8. Riahi, 2010, Signaling and cytotoxic functions of 4-hydroxyalkenals, Am. J. Physiol. Endocrinol. Metab., 299, E879, 10.1152/ajpendo.00508.2010 · DOI · Paper page
  9. Forman, 2010, Reactive oxygen species and α,β-unsaturated aldehydes as second messengers in signal transduction, Oxid. Nitrosative Stress Dis., 1203, 35
  10. Higdon, 2012, Cell signalling by reactive lipid species: New concepts and molecular mechanisms, Biochem. J., 442, 453, 10.1042/BJ20111752 · DOI · Paper page
  11. Dwivedi, 2007, Role of 4-hydroxynonenal and its metabolites in signaling, Redox Rep., 12, 4, 10.1179/135100007X162211 · DOI
  12. Ayala, A., Munoz, M.F., and Argueelles, S. (2014). Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. · DOI · Paper page
  13. Spickett, 2013, The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis, Redox Biol., 1, 145, 10.1016/j.redox.2013.01.007 · DOI · Paper page
  14. LoPachin, 2009, Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: Nucleophilic targets and adduct formation, Chem. Res. Toxicol., 22, 1499, 10.1021/tx900147g · DOI · Paper page
  15. Mattson, 2009, Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders, Exp. Gerontol., 44, 625, 10.1016/j.exger.2009.07.003 · DOI · Paper page
  16. Guichardant, 2009, Analysis of biomarkers from lipid peroxidation: A comparative study, Eur. J. Lipid Sci. Technol., 111, 75, 10.1002/ejlt.200800069 · DOI
  17. Pryor, W.A. (1980). Free Radicals in Biology, Academic Press.
  18. Tsunada, 2003, Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione, Dig. Dis. Sci., 48, 210, 10.1023/A:1021775524062 · doi:10.1023/a:1021775524062
  19. Bochkov, 2002, Protective role of phospholipid oxidation products in endotoxin-induced tissue damage, Nature, 419, 77, 10.1038/nature01023 · DOI · Paper page
  20. Yin, 2004, Identification of a novel class of endoperoxides from arachidonate autoxidation, J. Biol. Chem., 279, 3766, 10.1074/jbc.M307137200 · DOI
  21. Poli, 2000, 4-Hydroxynonenal in the pathomechanisms of oxidative stress, Iubmb Life, 50, 315
  22. Pillon, 2010, Quantitative structure-activity relationship for 4-hydroxy-2-alkenal induced cytotoxicity in L6 muscle cells, Chem. Biol. Interact., 188, 171, 10.1016/j.cbi.2010.06.015 · DOI
  23. Vazdar, 2012, Behavior of 4-hydroxynonenal in phospholipid membranes, J. Phys. Chem. B, 116, 6411, 10.1021/jp3044219 · DOI
  24. Dabrowski, 2010, Stereoselective Effects of 4-hydroxynonenal in cultured mouse hepatocytes, Chem. Res. Toxicol., 23, 1601, 10.1021/tx100190k · DOI
  25. Hiratsuka, 2001, (S)-preferential cytotoxicity of 4-hydroxy-2(E)-nonenal enantiomers in rat Clone 9 cells, Toxicology, 164, 199
  26. Gueraud, 2005, Enantioselective metabolism of (R)- and (S)-4-hydroxy-2-nonenal in rat, Biofactors, 24, 97, 10.1002/biof.5520240111 · doi:10.1002/biof.5520240111
  27. Sadhukhan, 2014, Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver, Free Rad. Biol. Med., 70, 78, 10.1016/j.freeradbiomed.2014.02.008 · DOI
  28. Wakita, 2009, Stereochemical configuration of 4-hydroxy-2-nonenal-cysteine adducts and their stereoselective formation in a redox-regulated protein, J. Biol. Chem., 284, 28810, 10.1074/jbc.M109.019927 · DOI
  29. Komisarski, 2009, Practical highly enantioselective synthesis of (R)- and (S)-(E)-4-hydroxynon-2-enal, Acta Biochim. Polonica, 56, 189, 10.18388/abp.2009_2532 · doi:10.18388/abp.2009_2532
  30. Yadav, U.C.S., and Ramana, K.V. (2013). Regulation of NF-kappaB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid. Med. Cell. Longevity. · DOI · Paper page
  31. Singh, 2009, Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-Hydroxynonenal (4-HNE), Aging, 1, 68, 10.18632/aging.100005 · DOI
  32. Singh, 2008, Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice, Biochemistry, 47, 3900, 10.1021/bi702124u · DOI
  33. Long, 2010, Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE, Free Rad. Biol. Med., 49, 1, 10.1016/j.freeradbiomed.2010.03.015 · DOI · Paper page
  34. Wang, 2013, Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages, Cancer Prev. Res., 6, 206, 10.1158/1940-6207.CAPR-12-0350 · DOI
  35. Kang, 2011, Hepatotoxicity and nephrotoxicity produced by 4-hydroxy-2-nonenal (4-HNE) following 4-week oral administration to sprague-dawley rats, J. Toxicol. Environ. Health Part A, 74, 779, 10.1080/15287394.2011.567952 · DOI
  36. Zhang, 2010, 4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway, J. Mol. Cell. Cardiol., 49, 576, 10.1016/j.yjmcc.2010.05.011 · DOI
  37. Mannervik, 2012, Five decades with glutathione and the GSTome, J. Biol. Chem., 287, 6072, 10.1074/jbc.X112.342675 · doi:10.1074/jbc.x112.342675
  38. Balogh, 2011, Interactions of glutathione transferases with 4-hydroxynonenal, Drug Metab. Rev., 43, 165, 10.3109/03602532.2011.558092 · DOI
  39. Rudd, 2011, Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1), Chem. Biol. Interact., 194, 113, 10.1016/j.cbi.2011.08.012 · DOI
  40. Shireman, 2010, Glutathione transferase A4-4 resists adduction by 4-hydroxynonenal, Arch. Biochem. Biophys., 504, 182, 10.1016/j.abb.2010.09.005 · DOI
  41. Zhou, 1999, Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products, J. Agric. Food Chem., 47, 51, 10.1021/jf980780j · DOI
  42. Zhu, 2009, Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenal, Chem. Res. Toxicol., 22, 1721, 10.1021/tx900221s · DOI
  43. Aldini, G., Yeum, K.J., Niki, E., and Russell, R.M. (2010). Biomarkers for Antioxidative Defense and Oxidative Damage, Blackwell Publishing. · DOI
  44. Wakita, 2011, A method for detection of 4-hydroxy-2-nonenal adducts in proteins, Free Radic. Biol. Med., 51, 1, 10.1016/j.freeradbiomed.2011.02.037 · DOI
  45. Zhang, 2011, Relating protein adduction to gene expression changes: A systems approach, Mol. Biosyst., 7, 2118, 10.1039/c1mb05014a · DOI
  46. Dick, 2001, Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase—A new role for leukotriene B-4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase, J. Biol. Chem., 276, 40803, 10.1074/jbc.M105487200 · DOI
  47. Chen, 1996, Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide, Chem. Res. Toxicol., 9, 306, 10.1021/tx9501389 · DOI
  48. Singh, 2013, Phenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal, J. Cerebral Blood Flow Metab., 33, 593, 10.1038/jcbfm.2012.211 · DOI
  49. Fournet, 2013, α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: Suppressors of apoptogenic aldehyde oxidation and activators of apoptosis, Curr. Med. Chem., 20, 527
  50. Guo, 2013, ALDH2 protects against stroke by clearing 4-HNE, Cell Res., 23, 915, 10.1038/cr.2013.69 · DOI · Paper page
  51. Ma, 2011, Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: Role of autophagy paradox and toxic aldehyde, Eur. Heart J., 32, 1025, 10.1093/eurheartj/ehq253 · DOI · Paper page
  52. Muzio, 2012, Aldehyde dehydrogenases and cell proliferation, Free Radic. Biol. Med., 52, 735, 10.1016/j.freeradbiomed.2011.11.033 · DOI · Paper page
  53. Townsend, 2001, Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells, Chem. Biol. Interact., 130–132, 261, 10.1016/S0009-2797(00)00270-2 · DOI
  54. Black, 2012, Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal, Free Radic. Biol. Med., 52, 1937, 10.1016/j.freeradbiomed.2012.02.050 · DOI
  55. 2012, Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts, Chem. Res. Toxicol., 25, 722, 10.1021/tx2005184 · DOI
  56. Murakami, 2009, Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde, Neurobiol. Aging, 30, 325, 10.1016/j.neurobiolaging.2007.07.002 · DOI
  57. Srivastava, 2009, Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein e-null mice, Circ. Res., 105, 793, 10.1161/CIRCRESAHA.109.200568 · DOI
  58. Keith, 2009, Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts, Chem. Biol. Interact., 178, 242, 10.1016/j.cbi.2008.10.055 · DOI
  59. Li, 2012, Human aldo-keto reductase AKR7A2 protects against the cytotoxicity and mutagenicity of reactive aldehydes and lowers intracellular reactive oxygen species in hamster V79-4 cells, Chem. Biol. Interact., 195, 25, 10.1016/j.cbi.2011.09.007 · DOI
  60. Jung, K.-A., and Kwak, M.-K. (2013). Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid. Med. Cell. Longevity. · DOI
  61. Lyon, 2013, Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells, Neurochem. Int., 62, 113, 10.1016/j.neuint.2012.10.007 · DOI
  62. Zhong, 2009, Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels, Biochem. Biophys. Res. Commun., 387, 245, 10.1016/j.bbrc.2009.06.123 · doi:10.1016/j.bbrc.2009.06.123
  63. Martin, 2009, Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes, Chem. Biol. Interact., 178, 145, 10.1016/j.cbi.2008.10.021 · DOI
  64. Endo, 2010, Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10), Arch. Biochem. Biophys., 503, 230, 10.1016/j.abb.2010.08.010 · DOI
  65. Matsunaga, 2011, Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal, Chem. Biol. Interact., 191, 364, 10.1016/j.cbi.2010.12.018 · DOI
  66. Marchette, 2010, Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells, Free Radic. Biol. Med., 48, 16, 10.1016/j.freeradbiomed.2009.08.005 · DOI
  67. Amunom, 2011, Cytochromes p450 catalyze the reduction of α,β-unsaturated aldehydes, Chem. Res. Toxicol., 24, 1223, 10.1021/tx200080b · DOI
  68. Zhang, 2009, Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs, J. Biol. Chem., 284, 33521, 10.1074/jbc.M109.055665 · DOI
  69. Berthiaume, J.M., Li, Q., Sadhukhan, S., Henry, F., Tochtrop, G.P., Brunengraber, H., and Zhang, G. (2013). Catabolism of 4-hydroxy-2(E)-nonenal (HNE) via omega oxidation in perfused rat livers. FASEB J., 27, Abstract No. 794.15. · doi:10.1096/fasebj.27.1_supplement.794.15
  70. Subramaniam, 1997, The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins, J. Neurochem., 69, 1161, 10.1046/j.1471-4159.1997.69031161.x · DOI · Paper page
  71. Chen, 1994, Alterations in mitochondrial-membrane fluidity by lipid-peroxidation products, Free Radic. Biol. Med., 17, 411, 10.1016/0891-5849(94)90167-8 · DOI · Paper page
  72. Barrier, 1999, Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes, Neurosci. Lett., 277, 91, 10.1016/S0304-3940(99)00652-7 · DOI
  73. Liu, 2013, RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenal, Mol. Biosyst., 9, 3036, 10.1039/c3mb70114j · DOI
  74. Schreier, 2010, Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE, Neurotox. Res., 17, 249, 10.1007/s12640-009-9099-9 · DOI
  75. Siems, 2003, Intracellular metabolism of 4-hydroxynonenal, Mol. Asp. Med., 24, 167, 10.1016/S0098-2997(03)00011-6 · DOI · Paper page
  76. Vila, 2008, Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives, Chem. Res. Toxicol., 21, 432, 10.1021/tx700347w · DOI · Paper page
  77. Tallman, K.A., Vila, A., Porter, N.A., and Marnett, L.J. (2009). Measuring electrophile stress. Curr. Protoc. Toxicol., 11–17. · DOI
  78. Chavez, 2010, Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: Protein carbonylation is diminished by ascorbic acid, Chem. Res. Toxicol., 23, 37, 10.1021/tx9002462 · DOI
  79. Codreanu, 2009, Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal, Mol. Cell. Proteomics, 8, 670, 10.1074/mcp.M800070-MCP200 · DOI
  80. Petersen, D.R., Carbone, D., and Doorn, J. (2006, January 16–18). Hepatocellular targets of 4-hydroxy-2-nonenal modification. Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy. Abstract No. 6.
  81. Hussain, 2006, Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats, Am. J. Physiol. Lung Cell. Mol. Physiol., 290, L996, 10.1152/ajplung.00337.2005 · DOI
  82. Jung, 2005, Distribution of oxidized and HNE-modified proteins in U87 cells, Biofactors, 24, 165, 10.1002/biof.5520240120 · doi:10.1002/biof.5520240120
  83. Carbone, 2005, Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease, J. Pharmacol. Exp. Ther., 315, 8, 10.1124/jpet.105.088088 · DOI · Paper page
  84. Carbone, 2004, Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal, Chem. Res. Toxicol., 17, 1459, 10.1021/tx049838g · DOI
  85. Legards, J.F., and des Rosiers, C. (2006, January 16–18). Assay of 4-hydroxynonenal (HNE) adducts with various polyaminoacids (PAA) using gas chromatography-mass spectrometry (GCMS). Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy.
  86. Doorn, 2003, Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal, Chem. Biol. Interact., 143, 93, 10.1016/S0009-2797(02)00178-3 · DOI
  87. Isom, 2004, Modification of cytochrome c by 4-hydroxy-2-nonenal: Evidence for histidine, lysine, and arginine-aldehyde adducts, J. Am. Soc. Mass Spectrom., 15, 1136, 10.1016/j.jasms.2004.03.013 · DOI
  88. Liu, 2003, Mass spectroscopic characterization of protein modification by 4-Hydroxy-2-(E)-nonenal and 4-Oxo-2-(E)-nonenal, Chem. Res. Toxicol., 16, 901, 10.1021/tx0300030 · DOI
  89. Aldini, 2005, Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction, J. Mass Spectrom., 40, 946, 10.1002/jms.872 · DOI
  90. Bennaars-Eiden, A., Higgins, L.A., Hertzel, A.V., Kapphahn, R.J., Ferrington, D., and Bernlohr, D.A. (2003). Covalent modification of epithelial fatty acid binding protein by 4-hydroxynonenal in vitro and in vivo: Evidence for a role in antioxidant biology. FASEB J., 17, Abstract No. 845.847. · DOI
  91. Carbone, 2005, Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase, Chem. Res. Toxicol., 18, 1324, 10.1021/tx050078z · DOI
  92. Asselin, 2006, Circulating 4-hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats, Free Radic. Biol. Med., 41, 97, 10.1016/j.freeradbiomed.2006.03.011 · DOI
  93. Moreau, 2005, Reversal by aminoguanidine of the age-related increase in glycoxidation and lipoxidation in the cardiovascular system of Fischer 344 rats, Biochem. Pharmacol., 69, 29, 10.1016/j.bcp.2004.09.006 · DOI
  94. Kim, 2006, Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 61, 332, 10.1093/gerona/61.4.332 · DOI
  95. Petersen, 2004, Reactions of 4-hydroxynonenal with proteins and cellular targets, Free Radic. Biol.Med., 37, 937, 10.1016/j.freeradbiomed.2004.06.012 · DOI · Paper page
  96. Renner, 2005, Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation, J. Heart Lung Transpl., 24, 730, 10.1016/j.healun.2004.02.021 · DOI
  97. Galligan, 2012, Protein carbonylation in a murine model for early alcoholic liver disease, Chem. Res. Toxicol., 25, 1012, 10.1021/tx300002q · DOI · Paper page
  98. Aoyama, 2006, Aging and oxidative stress in progressive supranuclear palsy, Eur. J. Neurol., 13, 89, 10.1111/j.1468-1331.2006.01139.x · DOI
  99. Grune, T. (, 2006). HNE-modified proteins: Formation, distribution and fate. Proceedings of the 3rd International Meeting of the HNE-Club, Genova, Italy. Abstract No. 17.
  100. Carbone, 2004, 4-hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase, Free Radic. Biol. Med., 37, 1430, 10.1016/j.freeradbiomed.2004.07.016 · DOI
  101. Okada, 1999, 4-hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress—Identification of proteasomes as target molecules, J. Biol. Chem., 274, 23787, 10.1074/jbc.274.34.23787 · DOI · Paper page
  102. Hyun, 2002, Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: A mechanism contributing to neurodegeneration?, J. Neurochem., 83, 360, 10.1046/j.1471-4159.2002.01125.x · DOI
  103. Li, 2005, The effect of ethanol-induced CYP2E1 on proteasome activity: The role of 4-hydroxynonenal, Exp. Mol. Pathol., 78, 109, 10.1016/j.yexmp.2004.10.005 · DOI
  104. Kessova, 2005, The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells, J. Pharmacol. Exp. Ther., 315, 304, 10.1124/jpet.105.088047 · doi:10.1124/jpet.105.088047
  105. Ferrington, 2004, Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal, FEBS Lett., 578, 217, 10.1016/j.febslet.2004.11.003 · DOI
  106. Tsuchiya, 2005, Degradation of glyceraldehyde-3-phosphate dehydrogenase triggered by 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal, Arch. Biochem. Biophys., 438, 217, 10.1016/j.abb.2005.04.015 · DOI
  107. Xu, 1999, Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (E)-4-hydroxy-2-nonenal, J. Org. Chem., 64, 5732, 10.1021/jo982523j · DOI
  108. Zarkovic, 2009, Protein-aldehydic adducts as biomarkers of oxidative stress, lipid peroxidation and oxidative homeostasis, Free Radic. Res., 43, 33
  109. Wang, 2013, Oxidative protein modification of soluble N-ethylmaleimide-sensitive factor attachment protein receptors, FASEB J., 27, 890
  110. Gallagher, 2006, Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria, Biochem. Pharmacol., 71, 1619, 10.1016/j.bcp.2006.02.018 · DOI
  111. Alary, 2003, Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat, Chem. Res.Toxicol., 16, 320, 10.1021/tx025671k · DOI
  112. Lucas, 2002, Effect of glutathione augmentation on lipid peroxidation after spinal cord injury, J. Neurotrauma, 19, 763, 10.1089/08977150260139138 · DOI
  113. Yang, 2003, Lipid peroxidation and cell cycle signaling: 4-Hydroxynonenal, a key molecule in stress mediated signaling, Acta Biochim. Polonica, 50, 319, 10.18388/abp.2003_3689 · DOI · Paper page
  114. Patrick, 2005, Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression, Biochem. Biophys. Res. Commun., 334, 425, 10.1016/j.bbrc.2005.06.099 · DOI
  115. Dwivedi, 2006, The course of CCl4 induced hepatotoxicity is altered in mGSTA4-4 null (−/−) mice, Toxicology, 218, 58, 10.1016/j.tox.2005.10.012 · DOI
  116. Engle, 2004, Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mGSTA4 null mouse, Toxicol. Appl. Pharmacol., 194, 296, 10.1016/j.taap.2003.10.001 · DOI
  117. Knoll, 2005, Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate, Toxicol. Sci., 86, 27, 10.1093/toxsci/kfi171 · DOI
  118. Srivastava, 2010, Synthesis, quantification, characterization, and signaling properties of glutathionyl conjugates of enals, Methods Enzymol., 474, 297, 10.1016/S0076-6879(10)74018-0 · DOI
  119. Spite, 2009, Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress, Br. J. Pharmacol., 158, 1062, 10.1111/j.1476-5381.2009.00234.x · DOI
  120. Aldini, 2005, Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives, Biofactors, 24, 77, 10.1002/biof.5520240109 · DOI · Paper page
  121. Aldini, 2002, Carnosine is a quencher of 4-hydroxy-nonenal: Through what mechanism of reaction?, Biochem. Biophys. Res. Commun., 298, 699, 10.1016/S0006-291X(02)02545-7 · DOI · Paper page
  122. Barski, 2013, Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein e-null mice, Arterioscler. Thromb. Vasc. Biol., 33, 1162, 10.1161/ATVBAHA.112.300572 · DOI
  123. Wang, 2012, Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization, Anal. Chem., 84, 4580, 10.1021/ac300695p · DOI
  124. Guiotto, 2005, Synthesis and evaluation of neuroprotective alpha,beta-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine, J. Med. Chem., 48, 6156, 10.1021/jm050507q · DOI
  125. Guiotto, 2005, Carnosine and carnosine-related antioxidants: A review, Curr. Med. Chem., 12, 2293, 10.2174/0929867054864796 · DOI · Paper page
  126. Vistoli, 2009, Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species, Chemmedchem, 4, 967, 10.1002/cmdc.200800433 · DOI
  127. Bertinaria, 2011, Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents, J. Med. Chem., 54, 611, 10.1021/jm101394n · DOI
  128. Sugano, 2013, Different anti-oxidant effects of thioredoxin 1 and thioredoxin 2 in retinal epithelial cells, Cell Struct. Funct., 38, 81, 10.1247/csf.12025 · DOI
  129. Zhang, 2014, Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal, Antioxid. Redox Signal., 21, 669, 10.1089/ars.2013.5499 · DOI
  130. Tang, 2011, A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c, J. Mass Spectrom., 46, 290, 10.1002/jms.1890 · DOI
  131. Gardner, 2001, Effect of 4-hydroxy-2(E)-nonenal on soybean lipoxygenase-1, Lipids, 36, 623, 10.1007/s11745-001-0766-9 · DOI
  132. Uchida, 1993, Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase—A possible involvement of intramolecular and intermolecular cross-linking reaction, J. Biol. Chem., 268, 6388, 10.1016/S0021-9258(18)53264-6 · DOI · Paper page
  133. Ishii, 2003, Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase, Biochemistry, 42, 3474, 10.1021/bi027172o · DOI
  134. Ploemen, 1997, Interactions of α,β-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1, Chem. Biol. Interact., 108, 67, 10.1016/S0009-2797(97)00096-3 · DOI
  135. Flohe, 1999, 4-Hydroxynonenal inhibits glutathione peroxidase: Protection by glutathione, Free Radic. Biol. Med., 26, 1383, 10.1016/S0891-5849(98)00335-9 · DOI
  136. Korotchkina, 2001, Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal, Free Radic. Biol. Med., 30, 992, 10.1016/S0891-5849(01)00491-9 · DOI
  137. Vilardo, 1998, Site-specific inactivation of aldose reductase by 4-hydroxynonenal, Arch. Biochem. Biophys., 350, 245, 10.1006/abbi.1997.0488 · DOI
  138. Yu, 2004, Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase—Modulation of selenoproteins by lipoxygenase enzymes, J. Biol. Chem., 279, 28028, 10.1074/jbc.M313939200 · DOI
  139. Fang, 2006, Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo, J. Am. Chem. Soc., 128, 1879, 10.1021/ja057358l · DOI · Paper page
  140. Chen, 2005, 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2, J. Biol. Chem., 280, 41921, 10.1074/jbc.M508556200 · DOI · Paper page
  141. Chen, 2006, Adaptive response induced by lipid peroxidation products in cell cultures, FEBS Lett., 580, 479, 10.1016/j.febslet.2005.12.045 · DOI
  142. Morquette, 2006, Production of lipid peroxidation products in osteoarthritic tissues—New evidence linking 4-hydroxynonenal to cartilage degradation, Arthritis Rheum., 54, 271, 10.1002/art.21559 · DOI
  143. Ramanathan, 2014, Covalent binding of 4-hydroxy-2-nonenal to lactate dehydrogenase decreases NADH formation and metmyoglobin reducing activity, J. Agric. Food Chem., 62, 2112, 10.1021/jf404900y · DOI
  144. Schlisser, 2010, Teratogen-induced oxidative stress targets glyceraldehyde-3-phosphate dehydrogenase in the organogenesis stage mouse embryo, Toxicol. Sci., 118, 686, 10.1093/toxsci/kfq287 · doi:10.1093/toxsci/kfq287
  145. Markesbery, 1999, Oxidative alterations in Alzheimer’s disease, Brain Pathol., 9, 133, 10.1111/j.1750-3639.1999.tb00215.x · DOI · Paper page
  146. Butterfield, 2002, Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress1,2, Free Radic. Biol. Med., 32, 1050, 10.1016/S0891-5849(02)00794-3 · DOI · Paper page
  147. Sultana, 2004, Oxidatively modified GST and MRP1 in Alzheimer’s disease brain: Implications for accumulation of reactive lipid peroxidation products, Neurochem. Res., 29, 2215, 10.1007/s11064-004-7028-0 · DOI
  148. Huang, 2012, Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal, Cell Biosci., 2, 1, 10.1186/2045-3701-2-40 · DOI
  149. Balogh, 2010, Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal, Biochemistry, 49, 1541, 10.1021/bi902038u · DOI
  150. Calamaras, 2012, Post-translational modification of serine/threonine kinase LKB1 via adduction of the reactive lipid species 4-hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly inhibits kinase activity, J. Biol. Chem., 287, 42400, 10.1074/jbc.M112.385831 · DOI
  151. Shearn, 2014, Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol, J. Biol. Chem., 289, 15449, 10.1074/jbc.M113.543942 · DOI · Paper page
  152. Wang, 2014, A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles, Nat. Methods, 11, 79, 10.1038/nmeth.2759 · DOI · Paper page
  153. Shearn, 2011, Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells, Biochemistry, 50, 3984, 10.1021/bi200029w · DOI
  154. MacDonald, 2013, Identification of ATP synthase as a lipid peroxide protein adduct in pancreatic islets from humans with and without type 2 Diabetes mellitus, J. Clin. Endocrinol. Metab., 98, E727, 10.1210/jc.2012-4203 · DOI
  155. Guo, 2011, Protein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria, J. Proteomics, 74, 2370, 10.1016/j.jprot.2011.07.009 · DOI
  156. Shearn, 2011, Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes, Mol. Pharmacol., 79, 941, 10.1124/mol.110.069534 · DOI
  157. Fang, 2013, Temporally controlled targeting of 4-hydroxynonenal to specific proteins in living cells, J. Am. Chem. Soc., 135, 14496, 10.1021/ja405400k · DOI
  158. Los, 2008, HatoTag: A novel protein labeling technology for cell imaging and protein analysis, ACS Chem. Biol., 3, 373, 10.1021/cb800025k · DOI · Paper page
  159. Fritz, 2011, 4-hydroxynonenal inhibits SIRT3 via thiol-specific modification, Chem. Res. Toxicol., 24, 651, 10.1021/tx100355a · DOI · Paper page
  160. Krohne, 2010, Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action, Exp. Eye Res., 90, 261, 10.1016/j.exer.2009.10.014 · DOI
  161. Wang, 2003, Oxidized neprilysin in aging and Alzheimer’s disease brains, Biochem. Biophys. Res. Commun., 310, 236, 10.1016/j.bbrc.2003.09.003 · DOI
  162. Wang, 2009, Effects of HNE-modification induced by A beta on neprilysin expression and activity in SH-SY5Y cells, J. Neurochem., 108, 1072, 10.1111/j.1471-4159.2008.05855.x · DOI
  163. Wang, 2010, N-Acetylcysteine prevents 4-hydroxynonenal—And amyloid-β-induced modification and inactivation of neprilysin in SH-SY5Y cells, J. Alzheimers Dis., 19, 179, 10.3233/JAD-2010-1226 · DOI
  164. Liu, 2013, Carbonylation of mitochondrial aconitase with 4-hydroxy-2-(E)-nonenal: Localization and relative reactivity of addition sites, Biochim. Biophys. Acta Proteins Proteomics, 1834, 1144, 10.1016/j.bbapap.2013.03.005 · DOI
  165. Zhao, 2014, Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment, Free Radic. Biol. Med., 72, 55, 10.1016/j.freeradbiomed.2014.03.001 · DOI
  166. Gentile, 2009, Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity, Biochem. J., 422, 285, 10.1042/BJ20090564 · DOI
  167. Muller, 2013, Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins, Antioxid. Redox Signal., 18, 731, 10.1089/ars.2012.4577 · DOI
  168. Aluise, 2013, Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles, Chem. Res. Toxicol., 26, 270, 10.1021/tx300449g · DOI
  169. Tanito, 2006, Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration, Free Radic. Biol. Med., 41, 1847, 10.1016/j.freeradbiomed.2006.09.012 · DOI
  170. Toyokuni, 2000, Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 Diabetes Mellitus, Antioxid. Redox Signal., 2, 681, 10.1089/ars.2000.2.4-681 · DOI
  171. Aldini, 2006, Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal, J. Mass Spectrom., 41, 1149, 10.1002/jms.1067 · DOI
  172. Liu, 2012, The reactivity of human serum albumin towards trans-4-hydroxy-2-nonenal, J. Mass Spectrom., 47, 411, 10.1002/jms.2037 · DOI
  173. Khatoon, 2012, Physicochemical and immunological studies on 4-hydroxynonenal modified HSA: Implications of protein damage by lipid peroxidation products in the etiopathogenesis of SLE, Hum. Immunol., 73, 1132, 10.1016/j.humimm.2012.08.011 · DOI
  174. Xiang, 2013, Oxidative stress-induced posttranslational modifications of human hemoglobin in erythrocytes, Arch. Biochem. Biophys., 529, 34, 10.1016/j.abb.2012.11.002 · DOI
  175. Naveena, 2010, Detection of 4-hydroxy-2-nonenal adducts of turkey and chicken myoglobins using mass spectrometry, Food Chem., 122, 836, 10.1016/j.foodchem.2010.02.062 · doi:10.1016/j.foodchem.2010.02.062
  176. Smathers, 2012, Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics, PLoS ONE, 7, e38459, 10.1371/journal.pone.0038459 · DOI · Paper page
  177. Hellberg, 2010, X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal, Protein Sci., 19, 1480, 10.1002/pro.427 · DOI
  178. Stewart, 2009, Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1791, 772, 10.1016/j.bbalip.2009.04.004 · DOI
  179. Shao, 2010, Modifying apolipoprotein A–I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway, J. Biol. Chem., 285, 18473, 10.1074/jbc.M110.118182 · DOI
  180. Zhu, 2009, Mass spectrometric characterization of protein modification by the products of nonenzymatic oxidation of linoleic acid, Chem. Res. Toxicol., 22, 1386, 10.1021/tx9000072 · doi:10.1021/tx9000072
  181. Ou, 2002, In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases, Exp. Neurol., 175, 363, 10.1006/exnr.2002.7923 · DOI
  182. Mattson, 2003, Neuronal and glial calcium signaling in Alzheimer’s disease, Cell Calcium, 34, 385, 10.1016/S0143-4160(03)00128-3 · DOI · Paper page
  183. Pedersen, 1998, Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients, Ann. Neurol., 44, 819, 10.1002/ana.410440518 · DOI · Paper page
  184. Lovell, 2012, 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures, J. Alzheimers Dis., 32, 139, 10.3233/JAD-2012-120409 · DOI
  185. Maroteaux, 1988, Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988 · DOI · Paper page
  186. Cabin, 2002, Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein, J. Neurosci., 22, 8797, 10.1523/JNEUROSCI.22-20-08797.2002 · DOI · Paper page
  187. Murphy, 2000, Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons, J. Neurosci., 20, 3214, 10.1523/JNEUROSCI.20-09-03214.2000 · DOI · Paper page
  188. Lotharius, 2002, Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson’s disease, Hum. Mol. Genet., 11, 2395, 10.1093/hmg/11.20.2395 · DOI · Paper page
  189. Jomova, 2010, Metals, oxidative stress and neurodegenerative disorders, Mol. Cell. Biochem., 345, 91, 10.1007/s11010-010-0563-x · DOI · Paper page
  190. Xiang, 2013, Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity, Mol. Cell. Neurosci., 54, 71, 10.1016/j.mcn.2013.01.004 · DOI
  191. Bae, 2013, Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of a-synuclein, Antioxid. Redox Signal., 18, 770, 10.1089/ars.2011.4429 · DOI
  192. Nasstrom, 2011, The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties, Free Radic. Biol. Med., 50, 428, 10.1016/j.freeradbiomed.2010.11.027 · DOI
  193. Shibata, 2010, Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy, Acta Histochem. Cytochem., 43, 69, 10.1267/ahc.10005 · DOI
  194. Chardonnet, 2011, Inhibition by 4-hydroxynonenal (HNE) of Ca2+ transport by SERCA1a: Low concentrations of HNE open protein-mediated leaks in the membrane, Free Radic. Biol. Med., 50, 323, 10.1016/j.freeradbiomed.2010.11.017 · DOI
  195. Gunthorpe, 2002, The diversity in the vanilloid (TRPV) receptor family of ion channels, Trends Pharmacol. Sci., 23, 183, 10.1016/S0165-6147(02)01999-5 · DOI · Paper page
  196. Kishimoto, 2011, Oxidative stress-induced posttranslational modification of TRPV1 expressed in esophageal epithelial cells, Am. J. Physiol. Gastrointest. Liver Physiol., 301, G230, 10.1152/ajpgi.00436.2009 · DOI
  197. Vindis, 2006, Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions—Prevention by Aldehyde Scavengers, Circ. Res., 98, 785, 10.1161/01.RES.0000216288.93234.c3 · DOI
  198. Shimozu, 2012, Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1, Biochem. J., 442, 171, 10.1042/BJ20111029 · DOI
  199. Kim, 2009, Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization, Chem. Biol. Interact., 182, 59, 10.1016/j.cbi.2009.07.009 · DOI
  200. Liu, 2005, Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations, Free Radic. Biol. Med., 38, 746, 10.1016/j.freeradbiomed.2004.11.005 · DOI

200 of 342 shown

Cited by

See all 232

Metadata

Authors
Schaur, R., Siems, W., Bresgen, N., & Eckl, P.
Venue
Biomolecules
Publisher
MDPI AG
Published
2015-09-30
Volume
5
Issue
4
Pages
2247-2337
ISSN
2218-273X (ISSN-L)
OpenAlex
W1757834753
Cited by
232
References
16
FWCI
10.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 4-Hydroxy-nonenal—A Bioactive Lipid Peroxidation Product. https://app.cochat.ai/papers/10.3390/biom5042247
The paper
Schaur, R., Siems, W., Bresgen, N., & Eckl, P. (2015). 4-Hydroxy-nonenal—A Bioactive Lipid Peroxidation Product. Biomolecules. https://doi.org/10.3390/biom5042247

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.